124 related articles for article (PubMed ID: 11750578)
1. Phosphorothioate/methoxyethyl-modified ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injury.
Stepkowski SM; Chen W; Bennett CF; Condon TP; Stecker K; Tian L; Kahan BD
Transplant Proc; 2001; 33(7-8):3705-6. PubMed ID: 11750578
[No Abstract] [Full Text] [Related]
2. Methoxyethyl modification of phosphorothioate ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injury.
Chen W; Bennett CF; Condon TP; Stecker K; Tian L; Kahan BD; Stepkowski SM
Transplant Proc; 2001; 33(1-2):854. PubMed ID: 11267100
[No Abstract] [Full Text] [Related]
3. Perfusion of kidneys with unformulated "naked" intercellular adhesion molecule-1 antisense oligodeoxynucleotides prevents ischemic/reperfusion injury.
Chen W; Bennett CF; Wang ME; Dragun D; Tian L; Stecker K; Clark JH; Kahan BD; Stepkowski SM
Transplantation; 1999 Sep; 68(6):880-7. PubMed ID: 10515390
[TBL] [Abstract][Full Text] [Related]
4. Methoxyethyl-modified intercellular adhesion molecule-1 antisense phosphorothiateoligonucleotides inhibit allograft rejection, ischemic-reperfusion injury, and cyclosporine-induced nephrotoxicity.
Chen W; Langer RM; Janczewska S; Furian L; Geary R; Qu X; Wang M; Verani R; Condon T; Stecker K; Bennett CF; Stepkowski SM
Transplantation; 2005 Feb; 79(4):401-8. PubMed ID: 15729165
[TBL] [Abstract][Full Text] [Related]
5. Development of antisense oligodeoxynucleotides for transplantation.
Stepkowski SM
Curr Opin Mol Ther; 2000 Jun; 2(3):304-17. PubMed ID: 11249625
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of hepatic ischemia/reperfusion injury with intercellular adhesion molecule-1 antisense oligodeoxynucleotides.
Ghobrial R; Amersi F; Stecker K; Kato H; Melinek J; Singer J; Mhoyan A; Busuttil RW; Kupiec-Weglinski JW; Stepkowski SM
Transplant Proc; 2001; 33(1-2):538. PubMed ID: 11266946
[No Abstract] [Full Text] [Related]
7. Prevention of renal ischemic reperfusion injury using FTY 720 and ICAM-1 antisense oligonucleotides.
Ortiz AM; Troncoso P; Kahan BD
Transplant Proc; 2003 Jun; 35(4):1571-4. PubMed ID: 12826223
[TBL] [Abstract][Full Text] [Related]
8. Antisense oligodeoxynucleotides for organ transplantation.
Stepkowski SM
Clin Biochem; 1998 Jul; 31(5):375-9. PubMed ID: 9721437
[No Abstract] [Full Text] [Related]
9. Antisense oligonucleotides for ICAM-1 attenuate reperfusion injury and renal failure in the rat.
Haller H; Dragun D; Miethke A; Park JK; Weis A; Lippoldt A; Gross V; Luft FC
Kidney Int; 1996 Aug; 50(2):473-80. PubMed ID: 8840275
[TBL] [Abstract][Full Text] [Related]
10. ICAM-1 antisense oligodesoxynucleotides prevent reperfusion injury and enhance immediate graft function in renal transplantation.
Dragun D; Tullius SG; Park JK; Maasch C; Lukitsch I; Lippoldt A; Gross V; Luft FC; Haller H
Kidney Int; 1998 Aug; 54(2):590-602. PubMed ID: 9690227
[TBL] [Abstract][Full Text] [Related]
11. The clinical experience of antisense therapy to ICAM-1 in Crohn's disease.
Yacyshyn B; Bowen-Yacyshyn MB; Shanahan W
Curr Opin Mol Ther; 1999 Jun; 1(3):332-5. PubMed ID: 11713798
[TBL] [Abstract][Full Text] [Related]
12. An oral formulation for intracellular adhesion molecules-1 antisense oligonucleotides.
Stepkowski SM; Chen W; Geary R; Wang ME; Condon T; Stecker K; Bennett CF
Transplant Proc; 2001; 33(7-8):3271. PubMed ID: 11750400
[No Abstract] [Full Text] [Related]
13. Diapedesis of leukocytes: antisense oligonucleotides for rescue.
Dragun D; Haller H
Exp Nephrol; 1999; 7(2):185-92. PubMed ID: 10213872
[TBL] [Abstract][Full Text] [Related]
14. The role of tissue factor in renal ischemic reperfusion injury by antisense oligodeoxynucleotide.
Matsuyama M; Akioka K; Okamoto M; Kadotani Y; Ushigome H; Nakamura K; Yoshimura R; Ohmori Y; Yoshimura N
Transplant Proc; 2002 Aug; 34(5):1475-6. PubMed ID: 12176446
[No Abstract] [Full Text] [Related]
15. Antisense phosphorothioate oligodeoxyribonucleotide targeted against ICAM-1: synthetic and biological characterization of a process-related impurity formed during oligonucleotide synthesis.
Ravikumar VT; Capaldi DC; Lima WF; Lesnik E; Turney B; Cole DL
Bioorg Med Chem; 2003 Oct; 11(21):4673-9. PubMed ID: 14527564
[TBL] [Abstract][Full Text] [Related]
16. Control of renal ischemic reperfusion injury by antisense oligodeoxynucleotide of tissue factor.
Matsuyama M; Akioka K; Okamoto M; Kadotani Y; Nakamura K; Ushigome H; Ohmori Y; Yoshimura R; Nakatani T; Yoshimura N
Transplant Proc; 2003 Feb; 35(1):103-4. PubMed ID: 12591326
[No Abstract] [Full Text] [Related]
17. Cationic lipid is not required for uptake and selective inhibitory activity of ICAM-1 phosphorothioate antisense oligonucleotides in keratinocytes.
Nestle FO; Mitra RS; Bennett CF; Chan H; Nickoloff BJ
J Invest Dermatol; 1994 Oct; 103(4):569-75. PubMed ID: 7930684
[TBL] [Abstract][Full Text] [Related]
18. Protection against allograft rejection with intercellular adhesion molecule-1 antisense oligodeoxynucleotides.
Stepkowski SM; Wang ME; Condon TP; Cheng-Flournoy S; Stecker K; Graham M; Qu X; Tian L; Chen W; Kahan BD; Bennett CF
Transplantation; 1998 Sep; 66(6):699-707. PubMed ID: 9771832
[TBL] [Abstract][Full Text] [Related]
19. Effect of antisense oligonucleotides for tissue factor on hepatic ischemia-reperfusion injury in the rat.
Nakamura K; Okamoto M; Akioka K; Matsuyama M; Yoshimura R; Ushigome H; Kadotani Y; Ohmori Y; Yoshimura N
Transplant Proc; 2001; 33(7-8):3707-8. PubMed ID: 11750579
[No Abstract] [Full Text] [Related]
20. Use of FTY 720 and ICAM-1 antisense oligonucleotides for attenuating chronic renal damage secondary to ischemia-reperfusion injury.
Troncoso P; Ortiz AM; DomÃnguez J; Kahan BD
Transplant Proc; 2005 Dec; 37(10):4284-8. PubMed ID: 16387098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
